Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Antimicrobial Resistance & Infection Control

Fig. 1

From: Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review

Fig. 1

Rate of MDRO acquisition per 1000 bed days by MDRO type. Error bars represent 95% confidence intervals. CRE Carbapenem-resistant Enterobacteriaceae; ESBL Extended spectrum beta lactamase; MDRO multi-drug resistant organism; MRSA Methicillin-resistant Staphylococcus aureus; VRE Vancomycin-resistant Enterococcus. Pseudomonas aeruginosa groups are defined by resistance to carbapenems (Group 1) or either piperacillin-tazobactam or cefepime (Group 2)

Back to article page